Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel I Bromage

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
JACC. Heart Failure|August 30, 2025
Inflammation in HFrEF: From Observation to Intervention?Antonio Cannata, Daniel I Bromage
ESC Heart Failure|February 19, 2026
Targeting inflammation in heart failure-from genetic evidence to therapeutic agentsMateusz Sokolski, Daniel I Bromage
European Journal of Heart Failure|March 2, 2026
Response to the letter by Mapelli et alDaniel I Bromage, Antonio Cannata
The International Journal of Biochemistry & Cell Biology|April 8, 2021
The innate immune response in myocarditisAbdullah Khawaja, Daniel I Bromage
Cardiovascular Diabetology|August 15, 2015
The pleiotropic effects of metformin: time for prospective studiesDaniel I Bromage, Derek M Yellon
European Heart Journal. Quality of Care & Clinical Outcomes|May 8, 2020
Cardiology after COVID-19: Quo Vademus?Antonio Cannata, Daniel I Bromage, Theresa McDonagh
European Journal of Heart Failure|April 28, 2022
COVID-19 and heart failure: the dark side of the moonAntonio Cannatà, Daniel I Bromage, Theresa A McDonagh
European Journal of Heart Failure|July 22, 2022
Combination diuretic therapy for acute heart failure: 'alone we can do so little; together we can do so much'Daniel I Bromage, Antonio Cannata, Theresa A McDonagh
European Journal of Heart Failure|November 13, 2023
When observation meets randomization: 'Don't let a crisis go to waste'Antonio Cannata, Daniel I Bromage, Theresa A McDonagh
Lancet (London, England)|November 8, 2022
Intravenous iron passes another endurance test in heart failureTheresa A McDonagh, Daniel I Bromage, Antonio Cannata
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
JACC. Heart Failure|August 30, 2025
Inflammation in HFrEF: From Observation to Intervention?Antonio Cannata, Daniel I Bromage
ESC Heart Failure|February 19, 2026
Targeting inflammation in heart failure-from genetic evidence to therapeutic agentsMateusz Sokolski, Daniel I Bromage
European Journal of Heart Failure|March 2, 2026
Response to the letter by Mapelli et alDaniel I Bromage, Antonio Cannata
The International Journal of Biochemistry & Cell Biology|April 8, 2021
The innate immune response in myocarditisAbdullah Khawaja, Daniel I Bromage
Cardiovascular Diabetology|August 15, 2015
The pleiotropic effects of metformin: time for prospective studiesDaniel I Bromage, Derek M Yellon
European Heart Journal. Quality of Care & Clinical Outcomes|May 8, 2020
Cardiology after COVID-19: Quo Vademus?Antonio Cannata, Daniel I Bromage, Theresa McDonagh
European Journal of Heart Failure|April 28, 2022
COVID-19 and heart failure: the dark side of the moonAntonio Cannatà, Daniel I Bromage, Theresa A McDonagh
European Journal of Heart Failure|July 22, 2022
Combination diuretic therapy for acute heart failure: 'alone we can do so little; together we can do so much'Daniel I Bromage, Antonio Cannata, Theresa A McDonagh
European Journal of Heart Failure|November 13, 2023
When observation meets randomization: 'Don't let a crisis go to waste'Antonio Cannata, Daniel I Bromage, Theresa A McDonagh
Lancet (London, England)|November 8, 2022
Intravenous iron passes another endurance test in heart failureTheresa A McDonagh, Daniel I Bromage, Antonio Cannata
Pageof 8